Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.08.20.607078

Physical activity modifies the metabolic profile of CD4+ and CD8+ T cell subtypes at rest and upon activation in older adults

Abstract

Aging reduces the functional competence of T cells. T cell metabolism regulates their function, with mitochondrial defects in mice resulting in aged phenotypes, including accelerated senescence. Physical activity (PA) maintains T cell function in older adults, although the mechanisms underlying this effect are poorly understood. This study examined the effects of aging on the metabolic profile of T cell subsets and investigated whether PA could improve metabolic function in T cells from older donors. We recruited nine young adults (23 {+/-} 3y) and 19 healthy older adults who had high PA (HPA, N=9, 75.5 {+/-} 4.7y) or low PA levels (LPA, N=10, 76.4 {+/-} 2.1y), based on their moderate-to-vigorous PA scores. We investigated the metabolic profiles of CD4+ and CD8+ T cells at rest and post-activation (PMA and ionomycin), via SCENITH flow cytometry. Compared to young adults, older adults had higher mitochondrial dependence (MD) in unstimulated CD4+ and CD8+ naive, effector memory (EM) and central memory (CM); and higher protein synthesis in CD4+ EM, CD4+ naive, CD8+ EM, suggesting higher energetic demand in T cells with aging. Upon activation there was a lower reduction in MD of CD4+ EMRA and CD8+ EMRA; and a greater increase in IL-6 and TNF expression in CD8+ cells of older than young adults, indicative of impaired metabolic flexibility with aging. PA effects were more prominent in unstimulated CD8+ cells, where HPA had lower glucose dependence (GD) for overall CD8+, CD8+EM and a trend to higher MD in CD8+ CM than LPA. Upon activation, HPA had a lower increase in CD4+ TNF expression and trended to have a higher reduction in MD of overall CD4+ and a higher reduction in GD of CD4+ EMRA, than LPA. This suggests a lower metabolic demand in CD4+ T cells of HPA. We concluded that PA could modify T cell metabolic profile at rest, and following activation, in older adults, which may explain the better T cell function in physically active older individuals.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Withnall, E., Hazeldine, J., Llibre, A., Duggal, N. A., Lord, J. M., Sardeli, A. V.. 2024-08-21. Physical activity modifies the metabolic profile of CD4+ and CD8+ T cell subtypes at rest and upon activation in older adults. https://doi.org/10.1101/2024.08.20.607078

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗